BI

Advertisement
Jan 07 2026HEALTH

Why Some Arthritis Treatments Fall Short

Psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA) are tough conditions to manage. Even with advanced treatments like tumor necrosis factor inhibitors (TNFis), many people don't get the relief they need. A recent study looked at how well these treatments work in the real world over a year

reading time less than a minute
Jan 07 2026HEALTH

Quick Tests for Autism: Are They Really Ready?

New tests for autism are popping up fast. But are they really ready to help? Scientists are still figuring out how to spot autism early. Yet, companies are already selling tests. Some check hair, skin, or even a mom's blood. They promise to tell if a baby might have autism. But experts say these tes

reading time less than a minute
Jan 07 2026HEALTH

New Hope for Kidney Disease: The Promise of ARNIs

ARNIs, or Angiotensin Receptor-Neprilysin Inhibitors, are making waves in the medical world. They're already changing the game for heart failure patients. Now, doctors are wondering if they can do the same for people with kidney disease. Neprilysin is a substance in the body. It breaks down certain

reading time less than a minute
Jan 07 2026ENTERTAINMENT

Is Timothée Chalamet Too Young for an Oscar?

Timothée Chalamet is making waves in the movie world. He is known for his dedication and hard work. In his latest movie, \"Marty Supreme, \" he plays a competitive table-tennis player. Many people think he will get his third Oscar nomination for this role. But there is a big challenge ahead. Winnin

reading time less than a minute
Jan 07 2026HEALTH

The Hurdles of Studying Cannabis with Human Subjects

Cannabis research with human subjects faces a big problem. The rules are not clear. This makes it hard for scientists to do their work. Many researchers want to study cannabis. But they hit roadblocks. The rules are not the same everywhere. This makes things confusing. Scientists often start their

reading time less than a minute
Jan 07 2026ENVIRONMENT

Venezuela's Oil: A Climate and Economic Challenge

Venezuela sits on a massive oil reserve, over 300 billion barrels, making it a tempting target for those eager to tap into its potential. The country's oil, however, is not just any oil. It's heavy, thick, and packed with impurities, making it one of the dirtiest oils in the world. Extracting this o

reading time less than a minute
Jan 07 2026BUSINESS

Big Pharma's Urgent Quest for New Drugs

Big Pharma companies are in a rush to buy biotech firms. Why? They face a huge problem. Many of their top-selling drugs will soon lose patent protection. This is called the "patent cliff. " By 2032, they could lose over $170 billion in sales. To avoid this, they need new drugs fast. That's where bi

reading time less than a minute
Jan 07 2026SCIENCE

How Scientists Built a Miniature Artery in a Lab

Scientists have figured out how to make tiny arteries in the lab that work like the real thing. They did this by copying how arteries stretch and move in the body. This is a big deal because it helps them study arteries and test new medicines. The team used two types of human cells: one from vein l

reading time less than a minute
Jan 07 2026POLITICS

Making Life More Affordable: A Realistic Plan

People are feeling the pinch. Everywhere they look, prices are high. Politicians are quick to promise solutions, but can they really deliver? Economists say no, not if they mean slashing prices across the board. That would take a major economic downturn. But people still want relief. So, what can p

reading time less than a minute
Jan 07 2026FINANCE

MicroStrategy Gets a Break: What's Next for Bitcoin Stocks?

MicroStrategy, a software company turned Bitcoin enthusiast, just got some good news. MSCI, a big name in finance, decided not to kick MicroStrategy out of its important stock index. This decision came after a lot of back and forth. MicroStrategy is known for holding a ton of Bitcoin. In fact, it's

reading time less than a minute